Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00622622
What this trial is testing

Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Wakayama Medical University 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT05300945
What this trial is testing

HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy

Who this might be right for
Gastric CancerPeritoneal Metastases
Zhixin Cao 200
Early research (Phase 1)Study completedNCT02008383
What this trial is testing

Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
John Strickler, M.D. 29
Large-scale testing (Phase 3)Study completedNCT00063141
What this trial is testing

Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eli Lilly and Company 1,302
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableActive Not RecruitingNCT01946854
What this trial is testing

Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei

Who this might be right for
Gastrointestinal Neoplasms
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07134205
What this trial is testing

The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Shanghai JMT-Bio Inc. 252
Early research (Phase 1)Looking for participantsNCT06833866
What this trial is testing

Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Advanced or Metastatic CRC
The Methodist Hospital Research Institute 33
Early research (Phase 1)Study completedNCT00101894
What this trial is testing

Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer

Who this might be right for
Rectal CancerColon Cancer
Amgen 119
Large-scale testing (Phase 3)Study completedNCT00069095
What this trial is testing

Capecitabine (Xeloda) and Bevacizumab as a First-line Therapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 2,035
Testing effectiveness (Phase 2)Ended earlyNCT00120172
What this trial is testing

Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerNeoplasm Metastasis
Geriatric Oncology Consortium 40
Testing effectiveness (Phase 2)Study completedNCT00054457
What this trial is testing

Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction

Who this might be right for
Esophageal CancerGastric Cancer
Alliance for Clinical Trials in Oncology 46
Testing effectiveness (Phase 2)Study completedNCT02509507
What this trial is testing

Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCutaneous or Subcutaneous Lymph Node+1 more
Amgen 127
Early research (Phase 1)Study completedNCT01497392
What this trial is testing

Dovitinib Lactate, Gemcitabine Hydrochloride, and Capecitabine in Treating Patients With Advanced or Metastatic Solid Tumors, Pancreatic Cancer and Biliary Cancers

Who this might be right for
Adenocarcinoma of the PancreasStage III Pancreatic CancerStage IV Pancreatic Cancer+1 more
Roswell Park Cancer Institute 26
Testing effectiveness (Phase 2)Ended earlyNCT00130936
What this trial is testing

Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates

Who this might be right for
Gastric CancerEsophageal CancerTumors
AHS Cancer Control Alberta 50
Testing effectiveness (Phase 2)Study completedNCT00867334
What this trial is testing

New Individualized Therapy Trial for Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmColorectal Cancer
Inova Health Care Services 10
Testing effectiveness (Phase 2)Study completedNCT00837239
What this trial is testing

Huachansu & Gemcitabine in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Study completedNCT05104567
What this trial is testing

SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)

Who this might be right for
Oesophageal Squamous Cell CarcinomaGastric CancerHepatocellular Carcinoma+2 more
Sanofi 138
Very early researchEnded earlyNCT00414570
What this trial is testing

An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs

Who this might be right for
Pancreatic Cancer
AHS Cancer Control Alberta 11
Early research (Phase 1)Study completedNCT00008294
What this trial is testing

Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Next Page